Company Overview of Ritter Pharmaceuticals, Inc.
Key Executives for Ritter Pharmaceuticals, Inc.
|Michael D. Step||16 Relationships||Chief Executive Officer and Director||56|
|Andrew J. Ritter||16 Relationships||Co-Founder, President and Director||33|
|Ira E. Ritter||16 Relationships||Co-Founder, Executive Chairman and Chief Strategic Officer||66|
|Ellen F. Mochizuki||No Relationships||Principal Financial Officer and Vice President of Finance||49|
|William M. Merino Ph.D.||No Relationships||Senior Clinical & Regulatory Advisor||--|
Ritter Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Ira E. Ritter||16 Relationships||Ritter Pharmaceuticals, Inc.||66|
|Michael D. Step||16 Relationships||Ritter Pharmaceuticals, Inc.||56|
|Andrew J. Ritter||16 Relationships||Ritter Pharmaceuticals, Inc.||33|
|Matthew W. Foehr||27 Relationships||Ligand Pharmaceuticals Incorporated||43|
|Paul V. Maier M.B.A.||59 Relationships||Apricus Biosciences, Inc.||68|
Ritter Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee M.B.A.||Paul V. Maier||59 Relationships||3 Executives|
|Compensation Committee||Matthew W. Foehr||27 Relationships||3 Executives|
|Nominating Committee||Gerald T. Proehl||60 Relationships||3 Executives|
|Corporate Governance Committee||Gerald T. Proehl||60 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$348.7K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.